Sio’s use of twitter, facebook, linkedin and social media

Sio is a user of Twitter and other social media properties and maintains a corporate Twitter account using the screen name: @SioGtx, a Facebook page with a username: @SioGeneTherapies, and a LinkedIn page.

Sio recognizes the importance of social media, including Twitter, Facebook, and LinkedIn, and new communication channels that enable Sio to engage in interactive discussion. As a clinical-stage biopharmaceutical company, Sio is committed to abide by the legal, ethical and regulatory standards applicable to the Company. Sio aims to have responsible social interactions.

Disclaimers

Sio may respond to questions and comments presented via Twitter, Facebook, LinkedIn, and other social media properties, when appropriate. Sio may not be able to immediately respond to questions or comments, and responses, if any, may be limited in nature.

There may be questions and/or comments Sio cannot address, including, but not limited to, questions related to non-public confidential information, proprietary information, financial matters, ongoing legal matters, regulatory issues and other aspects of Sio’s business. Sio will not respond to rumors, personal attacks, foul language, disparaging comments or topics that do not relate directly to Sio.

Twitter accounts that Sio follows or is followed by do not indicate an endorsement of the account owner or their products and services.

Sio may provide links or references to external websites, not controlled by Sio, as part of its Tweets or posts. However, Sio does not endorse or claim responsibility for the content of such other websites. Any links or references to such external websites are provided as merely a convenience to the users of the Twitter platform.

Sio reserves all rights relating to the Sio Twitter account (@SioGtx), Sio Facebook page (@SioGeneTherapies), Sio LinkedIn page, and its other social media properties including, but not limited to, all rights to add, remove or modify any content or material posted on the account, discontinue the account, accept or reject those who may wish to follow the account and respond to, or refrain from responding to, any questions or comments addressed to the account.